🔥🐔 BizChicken 🐔🔥
Companies Similar to Fortrea Holdings Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Certara, Inc.
Biosimulation Software and Services
Certara, Inc. provides biosimulation software and technology-enabled services for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access, helping to guide new drugs through the regulatory process to patients.
About | About | Locations | Leadership | About | News | About | Contact | Our Story | Careers | Jobs | Jobs | Culture | Benefits | Culture | Benefits | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About
Symbol: CERT
Recent Price: $10.54
Industry: Medical - Healthcare Information Services
CEO: Dr. William F. Feehery Ph.D.
Sector: Healthcare
Employees: 1338
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609 716 7900
Leadership
- William F. Feehery, Chief Executive Officer
- John E. Gallagher III, Chief Financial Officer
- Max Kanevsky, Chief Technology Officer
- Leif E. Pedersen, President, Chief Commercial Officer
- Rona Anhalt, Chief Human Resources Officer
- Ron DiSantis, SVP of Corporate Development
- Robert Aspbury, President, Certara Scientific Software
- Daniel Corcoran, Chief Counsel
- Sheila Rocchio, Chief Marketing Officer
- Patrick F. Smith, President, Certara Drug Development Solutions
- James E. Cashman III, Chairman of the Board
- Eran Broshy,
- Cynthia Collins,
- Rosemary Crane,
- Nancy Killefer,
- Stephen McLean,
- Matthew Walsh,
- David Spaight,
- John Reynders,
Last updated: 2024-12-31
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Fortrea Holdings Inc.
Biopharmaceutical and Medical Device Development Services
Fortrea Holdings Inc. is a contract research organization that provides biopharmaceutical product and medical device development services worldwide, offering clinical and enabling services for pharmaceutical, biotechnology, and medical device organizations.
About | About | Locations | About | Leadership | News | Events | About | Culture | About | Safety | About | About | Contact | Contact | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: FTRE
Recent Price: $18.43
Industry: Biotechnology
CEO: Mr. Thomas H. Pike
Sector: Healthcare
Employees: 16000
Address: 8 Moore Drive, Durham, NC 27709
Phone: (480)-295-7600
Leadership
- Tom Pike, President and CEO
- Jill McConnell, Chief Financial Officer
- Mark Morais, Chief Operating Officer & President of Clinical Services
- Oren Cohen, MD, Chief Medical Officer & President of Clinical Pharmacology
- Sandy Kennedy, Chief Quality, Regulatory Affairs & Sustainability Officer
- Drayton Virkler, President, Commercial
- John Doyle, DrPH, President, Consulting
- Alejandro Martinez Galindo, Chief Information Officer
- Dave Cooper, Chief Administrative Officer
- Stillman Hanson, General Counsel
- Georgina Strickland, Chief of Staff, Head of Strategy
Last updated: 2024-12-31
KORU Medical Systems, Inc.
FREEDOM infusion systems
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices for ambulatory infusion, offering products like the FREEDOM infusion systems including the FREEDOM60 and Freedom Edge syringe drivers, among others.
Symbol: KRMD
Recent Price: $3.89
Industry: Medical - Instruments & Supplies
CEO: Ms. Linda M. Tharby
Sector: Healthcare
Employees: 82
Address: 24 Carpenter Road, Chester, NY 10918
Phone: 845 469 2042
Last updated: 2024-12-31
Medpace Holdings, Inc.
Clinical Research-Based Drug and Medical Device Development Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services across North America, Europe, and Asia, supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
About | About | About | About | About | Leadership | About | Locations | About | Contact | Contact | About | About | DEI | Benefits | About | About | Careers | Careers | Jobs | Locations | Careers | Careers | Careers | Careers | Jobs | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Site Map | About | About | About
Symbol: MEDP
Recent Price: $333.34
Industry: Medical - Diagnostics & Research
CEO: Dr. August James Troendle M.D.
Sector: Healthcare
Employees: 5900
Address: 5375 Medpace Way, Cincinnati, OH 45227
Phone: 513 579 9911
Leadership
- August Troendle, MD, Chief Executive Officer & Chairman of the Board of Directors
- Jesse Geiger, President
- Susan Burwig, MA, BSN, Executive Vice President, Operations
- Weimin Gai, MS, Senior Vice President,Biometrics
- Reinilde Heyrman, MD, Chief Medical Officer, Medical Department
- Gina Leisring, MPH, Senior Vice President, Clinical Monitoring
- Traci Turner, MD, Vice President, MRL Operations and MARC
- Brad Hansman, Vice President, Site Activation & Maintenance
- Kevin Brady, Chief Financial Officer
- Amy Gasser Callow, JD, Vice President, Human Resources and Assistant General Counsel
- Brandon Ebken, Chief Information Officer
- Stephen Ewald, JD, General Counsel, Chief Compliance Officer and Corporate Secretary
- Jennifer Ruth, Vice President, Quality Assurance and Process Improvement
- Todd Meyers, Vice President, Business Development and Marketing
- John T. Wynne, MBA, Senior Vice President, Commercial Operations and Phase I Unit
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Royalty Pharma plc
biopharmaceutical royalties
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry, collaborating with various partners to acquire royalties on marketed and development-stage therapies in multiple therapeutic areas.
Contact | Contact | About | About | News | About | About | News | About | About | About | About
Symbol: RPRX
Recent Price: $25.32
Industry: Biotechnology
CEO: Mr. Pablo Gerardo Legorreta
Sector: Healthcare
Employees: 75
Address: 110 East 59th Street, New York, NY 10022
Phone: 212 883 0200
Last updated: 2024-12-31
Pfizer Inc.
biopharmaceutical products
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.
About | About | About | About | About | About | About | About | About | About | DEI | ESG | About | Safety | About | ESG | About | About | About | About | About | About | About | About | About | About | History | About | About | About | About | About | About | News | About | Directors | Contact | Careers | Careers | Careers | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: PFE
Recent Price: $26.42
Industry: Drug Manufacturers - General
CEO: Dr. Albert Bourla D.V.M., Ph.D.
Sector: Healthcare
Employees: 88000
Address: 235 East 42nd Street, New York, NY 10017
Phone: 212 733 2323
Last updated: 2024-12-31
Biora Therapeutics, Inc.
oral biotherapeutics
Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.
About | Leadership | About | Contact | Contact | Careers | Careers | About | Careers | Careers | About | About
Symbol: BIOR
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Aditya P. Mohanty M.B.A.
Sector: Healthcare
Employees: 58
Address: 4330 La Jolla Village Drive, San Diego, CA 92122
Phone: 855 293 2639
Leadership
- Adi Mohanty, MBA, Chief Executive Officer & Board Member
- Eric d’Esparbes, Chief Financial Officer
- Robyn Hatton, Head of Human Resources
- Ariella Kelman, MD, Chief Medical Officer
- James Knight, MBA, Head of Business Development
- Clarke Neumann, JD, General Counsel and Secretary
- Paul Shabram, MBA, Head of Technical Operations
- Sharat Singh, PhD, Head of Research
- Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
- Jeffrey Alter, MBA, Board Chair
- Jeffrey Ferrell, Board Member
- Jill Howe, Board Member
- Brian Kotzin, MD, Board Member
- Lynne Powell, MBA, Board Member
- Bruce Sands, MD, MS, Advisory Board Chair
- Geert D’Haens, MD, PhD, Advisory Board Member
- Brian Feagan, MD, FRCPC, Advisory Board Member
- Séverine Vermeire, MD, PhD, Advisory Board Member
- Satish Rao, MD, PhD, Advisory Board Chair
- William Chey, MD, Advisory Board Member
- Anthony Lembo, MD, Advisory Board Member
- Mark Pimentel, MD, Advisory Board Member
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Fortress Biotech, Inc.
Pharmaceutical and Biotechnology Products
Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.
About | About | About | Leadership | Directors | About | About | Contact | Careers | Careers | Careers | About | About | About
Symbol: FBIO
Recent Price: $2.18
Industry: Biotechnology
CEO: Dr. Lindsay Allan Rosenwald
Sector: Healthcare
Employees: 186
Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154
Phone: 781 652 4500
Leadership
- Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
- Michael S. Weiss, Executive Vice Chairman, Strategic Development
- David Jin, Chief Financial Officer and Head of Corporate Development
- George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
- Samuel Berry, General Counsel and Corporate Secretary
- Jimmie Harvey, Jr., M.D., Director
- Malcolm Hoenlein, Director
- Dov Klein, Director
- J. Jay Lobell, Director
- Kevin L. Lorenz, J.D., Director
- Lucy Lu, M.D., Director
Last updated: 2024-12-31
Forte Biosciences, Inc.
FB-102
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas, developing the FB-102 program for autoimmune diseases like vitiligo and alopecia areata.
Symbol: FBRX
Recent Price: $21.14
Industry: Biotechnology
CEO: Dr. Paul A. Wagner Ph.D.
Sector: Healthcare
Employees: 11
Address: 3060 Pegasus Park Drive, Dallas, TX 75247
Phone: 310 618 6994
Last updated: 2024-12-31
PTC Therapeutics, Inc.
Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.
About | History | Leadership | About | Contact | Careers | Careers | Jobs | About | About | About | About
Symbol: PTCT
Recent Price: $45.77
Industry: Biotechnology
CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Sector: Healthcare
Employees: 988
Address: 100 Corporate Court, South Plainfield, NJ 07080
Phone: 908 222 7000
Leadership
- Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
- Neil Almstead, Ph.D., Chief Technical Operations Officer
- John Baird, Ph.D., Chief of Staff to the CEO
- Mark E. Boulding, Executive Vice President and Chief Legal Officer
- Lee Golden, M.D., Chief Medical Officer
- Pierre Gravier, Chief Financial Officer
- Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
- Linda Montella-Carter, Senior Vice President and Chief Information Officer
- Eric Pauwels, Chief Business Officer
- Hege Sollie-Zetlmayer, Chief Human Resources Officer
- Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
- Michael Schmertzler, Chairman
- William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
- Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
- Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
- Emma Reeve, Independent Board Director
- Mary Smith, The VENG Group
- David P. Southwell, Former CEO, TScan Therapeutics
- Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
- Alethia Young, Chief Financial Officer, Bicycle Therapeutics
- Jerome B. Zeldis, M.D., Ph.D., Independent Board Director
Last updated: 2024-12-31
scPharmaceuticals Inc.
FUROSCIX
sc Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing pharmaceutical products, with a lead product candidate, FUROSCIX, aimed at treating congestion in heart failure patients using an on-body infusor.
About | Leadership | Contact | Contact | Careers | About | About | About | About | Careers | Careers | Careers | Careers | About | About | About
Symbol: SCPH
Recent Price: $3.50
Industry: Biotechnology
CEO: Mr. John H. Tucker
Sector: Healthcare
Employees: 135
Address: 2400 District Avenue, Burlington, MA 01803
Phone: 617 517 0730
Leadership
- John H. Tucker, President and Chief Executive Officer
- Rachael Nokes, Chief Financial Officer
- Mike Hassman, Senior Vice President, Technical Operations
- John Mohr, Pharm.D., FIDP, Senior Vice President, Clinical Development and Medical Affairs
- William T. Abraham, MD,
- Mette Kirstine Agger, Co-Founder & CEO, 7TM Pharma A/S
- Minnie V. Baylor-Henry, President, B-Henry & Associates
- Sara Bonstein, CFO, Insmed Incorporated
- Frederick Hudson, Former Partner in Charge of KPMG’s Largest Healthcare Industry Audit Practice Located in the Mid-Atlantic Region
- Jack A. Khattar, Founder, President & Chief Executive Officer, Supernus Pharmaceuticals
- Leonard D. Schaeffer, Founding Chairman & CEO, Wellpoint
- Klaus Veitinger, MD, PhD, Venture Partner, Orbimed
- Dan Bensimhon, MD, Medical Director Advanced Heart Failure & Mechanical Circulatory Support Program, Cone Health, Greensboro, NC
- G. Michael Felker, MD, Chief, Heart Failure Service, Division of Cardiology, Duke University School of Medicine
- Marv Konstam, MD, Professor of Medicine, Tufts University School of Medicine, Chief Physician Executive of the Cardiovascular Center at Tufts Medical Center
- W. Frank Peacock, MD, FACEP, FACC, FESC, Professor, Vice Chair of Research, Department of Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital
- Stuart Russell, MD, Regional Director of Heart Failure Program, Duke University School of Medicine
- James E. Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, Professor of Medicine and Radiology Tufts University School of Medicine
- William Weintraub, MD, Director of Outcomes Research, MedStar Heart and Vascular Institute
Last updated: 2024-12-31
Sutro Biopharma, Inc.
Xpress CF+
Sutro Biopharma, Inc. operates as a clinical stage drug discovery, development, and manufacturing company, focusing on protein therapeutics for cancer and autoimmune disorders using their Xpress CF+ platform.
About | About | News | About | Leadership | Leadership | About | About | About | Contact | About | About | About | Careers | Leadership | About | Leadership | Leadership | Leadership | About | About | About | About | Careers | About | About | About
Symbol: STRO
Recent Price: $1.85
Industry: Biotechnology
CEO: Mr. William J. Newell J.D.
Sector: Healthcare
Employees: 304
Address: 111 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 881 6500
Leadership
- John Doe, CEO
- Jane Smith, CTO
- Emily Johnson, Chief Financial Officer
- Michael Brown, President
- Linda Davis, Chairman
- James Wilson, Founder
Last updated: 2024-12-31
TruBridge, Inc.
healthcare solutions and services
Tru Bridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and healthcare systems globally, focusing on Revenue Cycle Management, Electronic Health Records, and Patient Engagement.
About | Leadership | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Careers | Careers | About | About | About | About | About | About | About | About | About | Management | About | About
Symbol: TBRG
Recent Price: $19.32
Industry: Medical - Healthcare Information Services
CEO: Mr. Christopher L. Fowler
Sector: Healthcare
Employees: 3219
Address: 54 St. Emanuel Street, Mobile, AL 36602
Phone: 251 639 8100
Leadership
- Chris Fowler, President and Chief Executive Officer
- David Dye, Chief Operating Officer
- Vinay Bassi, Chief Financial Officer
- Wes Cronkite, Chief Technology & Innovation Officer
- Amaris McComas, Chief People Officer
- Kevin Plessner, General Counsel and Corporate Compliance Officer
- Tracey Schroeder, Chief Marketing Officer
- Dawn Severance, Chief Sales Officer
- Glenn P. Tobin, Chairman of the Board
- Mark V. Anquillare, Director
- Regina M. Benjamin, Director
- David A. Dye, Director
- Chris L. Fowler, Director
- Christopher T. Hjelm, Director
- Denise W. Warren, Director
- Amy O’Keefe, Director
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Forge Global Holdings, Inc.
Forge Markets
Forge Global Holdings, Inc. provides marketplace infrastructure, data services, and technology solutions for private market participants, facilitating the trading of private company shares with accredited investors.
About | About | Locations | Careers | About | About | About | About | About | About | About | About | About | About | About | About | Culture
Symbol: FRGE
Recent Price: $0.90
Industry: Software - Application
CEO: Mr. Kelly A. Rodriques
Sector: Technology
Employees: 345
Address: 415 Mission Street, San Francisco, CA 94105
Phone: 415 881 1612
Last updated: 2024-12-31
Fortive Corporation
Professional and Engineered Products, Software, and Services
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide across various verticals, including manufacturing and healthcare.
Careers | Contact | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | About | About | About | About | About
Symbol: FTV
Recent Price: $75.04
Industry: Hardware, Equipment & Parts
CEO: Mr. James A. Lico
Sector: Technology
Employees: 18000
Address: 6920 Seaway Boulevard, Everett, WA 98203
Phone: 425 446 5000
Last updated: 2024-12-31
Arcturus Therapeutics Holdings Inc.
RNA medicines
Arcturus Therapeutics Holdings Inc. focuses on developing vaccines for infectious and rare diseases, including programs for cystic fibrosis and ornithine transcarbamylase deficiency. The company collaborates with various partners for vaccine and therapeutic development.
Symbol: ARCT
Recent Price: $16.58
Industry: Biotechnology
CEO: Mr. Joseph E. Payne M.Sc.
Sector: Healthcare
Employees: 180
Address: 10628 Science Center Drive, San Diego, CA 92121
Phone: 858 900 2660
Last updated: 2024-12-31